SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001213900-19-009006
Filing Date
2019-05-16
Accepted
2019-05-16 16:12:56
Documents
1
Effectiveness Date
2019-05-16
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11896
  Complete submission text file 0001213900-19-009006.txt   13094
Mailing Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE, 9TH FLOOR NEW YORK NY 10017 212-547-9591
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: D | Act: 33 | File No.: 021-339798 | Film No.: 19832373
SIC: 2834 Pharmaceutical Preparations